Bronchopulmonary dysplasia: Pathway from disease to long-term outcome

Journal of Perinatology

Volumn 28, Issue 12, 2008, Pages 837-840

  Lefkowitz, W ^a   Rosenberg, S H ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b Private Practice ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CLINICAL PRACTICE; DISEASE COURSE; DISEASE SEVERITY; EXTREMELY LOW BIRTH WEIGHT; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LUNG DYSPLASIA; LUNG FUNCTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN CARE; NEWBORN MONITORING; NOTE; OUTCOME ASSESSMENT; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; SURVIVAL RATE; WHEEZING;

BRONCHOPULMONARY DYSPLASIA; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; TIME FACTORS;

EID: 57049181465     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.110     Document Type: Note

References (24)

1. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. N Engl J Med 1967; 276: 357-368.
2. Stocker JT. Pathologic features of long-standing 'healed' bronchopulmonary dysplasia. Hum Pathol 1986; 17: 943-961.
3. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
4. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81.
5. Jobe AJ. The new BPD: An arrest of lung development. Pediatr Res 1999; 46(6): 641-643.
6. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 219-226.
7. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al. Validation of the national institutes of health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116 1353-1360.
8. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: Prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-532.
9. Davis PG, Thorpe K, Roberts R, Schmidt B, Doyle LW, Kirpalani H. Evaluating 'old' definitions for the 'new' bronchopulmonary dysplasia. J Pediatr 2002; 140: 555-560.
10. Palta M, Sadek M, Barnet JH, Evans M, Weinstein MR, McGuinness G et al. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. J Pediatr 1998; 132(1): 57-63.
11. Grégoire MC, Lefebvre F, Glorieux J. Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia. Pediatrics 1998; 101(5): 856-860.
12. Greenough A, Giffen FJ, Yüksal B, Dimitriou G. Respiratory morbidity in young school children born prematurely - chronic lung disease is not a risk factor? Eur J Pediatr 1996; 155(9): 823-826.
13. Jobe AH. The new BPD. NeoReviews 2006; 7: E531-e545.
14. Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 164-170.
15. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114: 1305-1311.
16. Thomas DV, Fletcher G, Sunshine P, Schafer IA, Klaus MH. Prolonged respirator use in pulmonary insufficiency of newborn. J Am Med Assoc 1965; 193(3): 183-190.
17. Tooley WH. Epidemiology of bronchopulmonary dysplasia. J Pediatr 1979; 95(5): 851-855.
18. Jobe AH, Bancalari E. NICHD/NHLBI/ORD workshop summary, bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
19. Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA et al Vitamin a supplementation for extremely-low-birth-weight infants. N Engl J Med 1999; 340: 1962-1968.
20. Ambalavanan N, Tyson JE, Kennedy KA, Hansen N, Vohr BR, Wright LL et al. Vitamin a supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 2005; 115: E249-e254. URL: www.pediatrics.org/cgi/doi/10.1542/peds.2004-1812.
21. Kothadia JM, O'Shea TM, Roberts D, Auringer ST, Weaver RG, Dillard RG. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants. Pediatrics 1999; 104: 22-27.
22. Nixon PA, Washburn LK, Schecter MS, O'Shea TM. Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: Effects on pulmonary outcomes at age 8 to 11 years. J Pediatr 2007; 150: 345-350.
23. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003; 111: 469-476.
24. Gappa M, Stocks J, Merkus P. Lung growth and development after preterm birth, further evidence (Letter). Am J Resp Crit Care Med 2003; 168: 399-400.